1. Home
  2. TECX vs RMNI Comparison

TECX vs RMNI Comparison

Compare TECX & RMNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$21.01

Market Cap

393.0M

Sector

N/A

ML Signal

HOLD

Logo Rimini Street Inc. (DE)

RMNI

Rimini Street Inc. (DE)

HOLD

Current Price

$3.43

Market Cap

329.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
RMNI
Founded
2019
2005
Country
United States
United States
Employees
51
N/A
Industry
Business Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
393.0M
329.4M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
TECX
RMNI
Price
$21.01
$3.43
Analyst Decision
Strong Buy
Buy
Analyst Count
5
2
Target Price
$80.40
$5.50
AVG Volume (30 Days)
529.5K
352.7K
Earning Date
01-01-0001
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
197.50
EPS
N/A
0.39
Revenue
N/A
$431,496,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.11
P/E Ratio
N/A
$9.21
Revenue Growth
N/A
5.33
52 Week Low
$13.70
$2.87
52 Week High
$27.64
$5.38

Technical Indicators

Market Signals
Indicator
TECX
RMNI
Relative Strength Index (RSI) 48.41 51.24
Support Level $20.52 $3.40
Resistance Level $25.39 $3.65
Average True Range (ATR) 2.35 0.16
MACD -0.23 0.04
Stochastic Oscillator 45.94 67.30

Price Performance

Historical Comparison
TECX
RMNI

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About RMNI Rimini Street Inc. (DE)

Rimini Street Inc and its subsidiaries are providers of end-to-end enterprise software support, products, and services. The Company offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, database, and technology software platforms. The Company derives revenues from clients by providing subscription support services for enterprise resource planning, customer relationship management, product lifecycle management database, and technology software systems. Geographically, the company generates the majority of its revenue from the United States of America and the International market.

Share on Social Networks: